{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T03:14:06Z","timestamp":1771038846013,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T00:00:00Z","timestamp":1533772800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s12149-018-1288-2","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T03:28:24Z","timestamp":1533785304000},"page":"642-648","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Predictive value of primary tumor parameters using 18F-FDG PET\/CT for occult lymph node metastasis in breast cancer with clinically negative axillary lymph node"],"prefix":"10.1007","volume":"32","author":[{"given":"Jang","family":"Yoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2520-7182","authenticated-orcid":false,"given":"Bom Sahn","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Jeon","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,9]]},"reference":[{"key":"1288_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jamcollsurg.2011.04.024","volume":"213","author":"SC Schiffman","year":"2011","unstructured":"Schiffman SC, McMasters KM, Scoggins CR, Martin RC, Chagpar AB. Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients. J Am Coll Surg. 2011;213:45\u201352 (discussion 52\u201353).","journal-title":"J Am Coll Surg"},{"key":"1288_CR2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/jnci\/djq008","volume":"102","author":"M Boer de","year":"2010","unstructured":"de Boer M, van Dijck JA, Bult P, Borm GF, Tjan-Heijnen VC. Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases. J Natl Cancer Inst. 2010;102:410\u201325.","journal-title":"J Natl Cancer Inst"},{"key":"1288_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11864-006-0049-y","volume":"7","author":"F Amersi","year":"2006","unstructured":"Amersi F, Hansen NM. The benefits and limitations of sentinel lymph node biopsy. Curr Treat Options Oncol. 2006;7:141\u201351.","journal-title":"Curr Treat Options Oncol"},{"key":"1288_CR4","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927\u201333.","journal-title":"Lancet Oncol"},{"key":"1288_CR5","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/SLA.0b013e3181c0e92a","volume":"251","author":"U Veronesi","year":"2010","unstructured":"Veronesi U, Viale G, Paganelli G, Zurrida S, Luini A, Galimberti V, et al. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg. 2010;251:595\u2013600.","journal-title":"Ann Surg"},{"key":"1288_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.breast.2016.07.021","volume":"29","author":"A Groef De","year":"2016","unstructured":"De Groef A, Van Kampen M, Tieto E, Schonweger P, Christiaens MR, Neven P, et al. Arm lymphoedema and upper limb impairments in sentinel node-negative breast cancer patients: a one year follow-up study. Breast. 2016;29:102\u20138.","journal-title":"Breast"},{"key":"1288_CR7","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.apmr.2015.01.014","volume":"96","author":"N Gebruers","year":"2015","unstructured":"Gebruers N, Verbelen H, De Vrieze T, Coeck D, Tjalma W. Incidence and time path of lymphedema in sentinel node negative breast cancer patients: a systematic review. Arch Phys Med Rehabil. 2015;96:1131\u20139.","journal-title":"Arch Phys Med Rehabil"},{"issue":"Suppl 1","key":"1288_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00259-004-1531-z","volume":"31","author":"F Crippa","year":"2004","unstructured":"Crippa F, Gerali A, Alessi A, Agresti R, Bombardieri E. FDG-PET for axillary lymph node staging in primary breast cancer. Eur J Nucl Med Mol Imaging. 2004;31(Suppl 1):97\u2013102.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1288_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/cncr.21568","volume":"106","author":"T Kim","year":"2006","unstructured":"Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer. 2006;106:4\u201316.","journal-title":"Cancer"},{"key":"1288_CR10","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1200\/JCO.2013.54.1177","volume":"32","author":"GH Lyman","year":"2014","unstructured":"Lyman GH, Temin S, Edge SB, Newman LA, Turner RR, Weaver DL, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2014;32:1365\u201383.","journal-title":"J Clin Oncol"},{"key":"1288_CR11","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1245\/ASO.2006.05.013","volume":"13","author":"LG Wilke","year":"2006","unstructured":"Wilke LG, McCall LM, Posther KE, Whitworth PW, Reintgen DS, Leitch AM, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol. 2006;13:491\u2013500.","journal-title":"Ann Surg Oncol"},{"key":"1288_CR12","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1245\/s10434-015-4403-9","volume":"22","author":"V Dialani","year":"2015","unstructured":"Dialani V, Chadashvili T, Slanetz PJ. Role of imaging in neoadjuvant therapy for breast cancer. Ann Surg Oncol. 2015;22:1416\u201324.","journal-title":"Ann Surg Oncol"},{"key":"1288_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ejrad.2008.07.039","volume":"69","author":"R Lavayssiere","year":"2009","unstructured":"Lavayssiere R, Cabee AE, Filmont JE. Positron emission tomography (PET) and breast cancer in clinical practice. Eur J Radiol. 2009;69:50\u20138.","journal-title":"Eur J Radiol"},{"key":"1288_CR14","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s10549-011-1780-z","volume":"131","author":"Y Wang","year":"2012","unstructured":"Wang Y, Zhang C, Liu J, Huang G. Is 18F-FDG PET accurate to predict neoadjuvant therapy response in breast cancer? A meta-analysis. Breast Cancer Res Treat. 2012;131:357\u201369.","journal-title":"Breast Cancer Res Treat"},{"key":"1288_CR15","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1007\/s12282-015-0629-4","volume":"23","author":"NY Jung","year":"2016","unstructured":"Jung NY, Kim SH, Kang BJ, Park SY, Chung MH. The value of primary tumor (18)F-FDG uptake on preoperative PET\/CT for predicting intratumoral lymphatic invasion and axillary nodal metastasis. Breast Cancer. 2016;23:712\u20137.","journal-title":"Breast Cancer"},{"key":"1288_CR16","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1007\/s00330-014-3452-y","volume":"25","author":"JY Kim","year":"2015","unstructured":"Kim JY, Lee SH, Kim S, Kang T, Bae YT. Tumour 18 F-FDG Uptake on preoperative PET\/CT may predict axillary lymph node metastasis in ER-positive\/HER2-negative and HER2-positive breast cancer subtypes. Eur Radiol. 2015;25:1172\u201381.","journal-title":"Eur Radiol"},{"key":"1288_CR17","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s12149-013-0720-x","volume":"27","author":"JW Seok","year":"2013","unstructured":"Seok JW, Kim Y, An YS, Kim BS. The clinical value of tumor FDG uptake for predicting axillary lymph node metastasis in breast cancer with clinically negative axillary lymph nodes. Ann Nucl Med. 2013;27:546\u201353.","journal-title":"Ann Nucl Med"},{"key":"1288_CR18","doi-asserted-by":"publisher","first-page":"e8557","DOI":"10.1097\/MD.0000000000008557","volume":"96","author":"YS An","year":"2017","unstructured":"An YS, Kang DK, Jung Y, Kim TH. Volume-based metabolic parameter of breast cancer on preoperative 18F-FDG PET\/CT could predict axillary lymph node metastasis. Medicine. 2017;96:e8557.","journal-title":"Medicine"},{"key":"1288_CR19","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1002\/cncr.29565","volume":"121","author":"S Chen","year":"2015","unstructured":"Chen S, Ibrahim NK, Yan Y, Wong ST, Wang H, Wong FC. Risk stratification in patients with advanced-stage breast cancer by pretreatment [(18) F]FDG PET\/CT. Cancer. 2015;121:3965\u201374.","journal-title":"Cancer"},{"key":"1288_CR20","first-page":"120","volume":"6","author":"B Marinelli","year":"2016","unstructured":"Marinelli B, Espinet-Col C, Ulaner GA, McArthur HL, Gonen M, Jochelson M, et al. Prognostic value of FDG PET\/CT-based metabolic tumor volumes in metastatic triple negative breast cancer patients. Am J Nucl Med Mol Imaging. 2016;6:120\u20137.","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"1288_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00259-009-1297-4","volume":"37","author":"R Boellaard","year":"2010","unstructured":"Boellaard R, O\u2019Doherty MJ, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG, et al. FDG PET and PET\/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2010;37:181\u2013200.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1003","key":"1288_CR22","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1259\/bjr\/56324742","volume":"84","author":"WH Choi","year":"2011","unstructured":"Choi WH, Yoo IR, O JH, Kim SH, Chung SK. The value of dual-time-point 18F-FDG PET\/CT for identifying axillary lymph node metastasis in breast cancer patients. Br J Radiol. 2011;84(1003):593\u20139.","journal-title":"Br J Radiol"},{"issue":"8","key":"1288_CR23","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/S0959-8049(02)00748-7","volume":"39","author":"EE Deurloo","year":"2003","unstructured":"Deurloo EE, Tanis PJ, Gilhuijs KG, Muller SH, Kroger R, Peterse JL, et al. Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer. Eur J Cancer. 2003;39(8):1068\u201373.","journal-title":"Eur J Cancer"},{"issue":"9","key":"1288_CR24","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1007\/s003300000370","volume":"10","author":"KA Kvistad","year":"2000","unstructured":"Kvistad KA, Rydland J, Smethurst HB, Lundgren S, Fjosne HE, Haraldseth O. Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI. Eur Radiol. 2000;10(9):1464\u201371.","journal-title":"Eur Radiol"},{"issue":"1","key":"1288_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.amjsurg.2006.02.021","volume":"193","author":"J Nori","year":"2007","unstructured":"Nori J, Vanzi E, Bazzocchi M, Bufalini FN, Distante V, Branconi F, et al. Role of axillary ultrasound examination in the selection of breast cancer patients for sentinel node biopsy. Am J Surg. 2007;193(1):16\u201320.","journal-title":"Am J Surg"},{"key":"1288_CR26","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"AC Wolff","year":"2013","unstructured":"Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update. J Clin Oncol. 2013;31:3997\u20134013.","journal-title":"J Clin Oncol"},{"key":"1288_CR27","doi-asserted-by":"publisher","first-page":"10277","DOI":"10.7314\/APJCP.2014.15.23.10277","volume":"15","author":"M Petric","year":"2014","unstructured":"Petric M, Martinez S, Acevedo F, Oddo D, Artigas R, Camus M, et al. Correlation between Ki67 and histological grade in breast cancer patients treated with preoperative chemotherapy. Asian Pac J Cancer Prev. 2014;15:10277\u201380.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1288_CR28","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1038\/sj.bjc.6603152","volume":"94","author":"GG Eynden Van den","year":"2006","unstructured":"Van den Eynden GG, Van der Auwera I, Van Laere SJ, Colpaert CG, van Dam P, Dirix LY, et al. Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study. Br J Cancer. 2006;94:1643\u20139.","journal-title":"Br J Cancer"},{"key":"1288_CR29","doi-asserted-by":"publisher","first-page":"e7657","DOI":"10.1097\/MD.0000000000007657","volume":"96","author":"J Yoo","year":"2017","unstructured":"Yoo J, Kim BS, Chung J, Yoon HJ. Percentage change of primary tumor on 18F-FDG PET\/CT as a prognostic factor for invasive ductal breast cancer with axillary lymph node metastasis: comparison with MRI. Medicine (Baltimore). 2017;96:e7657.","journal-title":"Medicine (Baltimore)"},{"key":"1288_CR30","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1007\/s00259-014-2803-x","volume":"41","author":"JW Lee","year":"2014","unstructured":"Lee JW, Cho A, Lee JH, Yun M, Lee JD, Kim YT, et al. The role of metabolic tumor volume and total lesion glycolysis on 18F-FDG PET\/CT in the prognosis of epithelial ovarian cancer. Eur J Nucl Med Mol Imaging. 2014;41:1898\u2013906.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1288_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1600-0587.2012.07348.x","volume":"36","author":"CF Dormann","year":"2013","unstructured":"Dormann CF, Elith J, Bacher S, Buchmann C, Carl G, Carre G, et al. Collinearity: a review of methods to deal with it and a simulation study evaluating their performance. Ecography. 2013;36:27\u201346.","journal-title":"Ecography"},{"key":"1288_CR32","doi-asserted-by":"publisher","first-page":"e3689","DOI":"10.1097\/MD.0000000000003689","volume":"95","author":"MJ Chung","year":"2016","unstructured":"Chung MJ, Lee JH, Kim SH, Suh YJ, Choi HJ. Simple prediction model of axillary lymph node positivity after analyzing molecular and clinical factors in early breast cancer. Medicine. 2016;95:e3689.","journal-title":"Medicine"},{"key":"1288_CR33","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.breast.2012.09.003","volume":"22","author":"E Yoshihara","year":"2013","unstructured":"Yoshihara E, Smeets A, Laenen A, Reynders A, Soens J, Van Ongeval C, et al. Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice. Breast. 2013;22:357\u201361.","journal-title":"Breast"},{"key":"1288_CR34","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3109\/02841851.2010.501342","volume":"51","author":"JH Ahn","year":"2010","unstructured":"Ahn JH, Son EJ, Kim JA, Youk JH, Kim EK, Kwak JY, et al. The role of ultrasonography and FDG-PET in axillary lymph node staging of breast cancer. Acta Radiol. 2010;51:859\u201365.","journal-title":"Acta Radiol"},{"key":"1288_CR35","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1245\/s10434-011-2200-7","volume":"19","author":"SA Valente","year":"2012","unstructured":"Valente SA, Levine GM, Silverstein MJ, Rayhanabad JA, Weng-Grumley JG, Ji L, et al. Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging. Ann Surg Oncol. 2012;19:1825\u201330.","journal-title":"Ann Surg Oncol"},{"key":"1288_CR36","doi-asserted-by":"publisher","first-page":"324","DOI":"10.6004\/jnccn.2016.0037","volume":"14","author":"WJ Gradishar","year":"2016","unstructured":"Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, et al. Invasive breast cancer version 1.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2016;14:324\u201354.","journal-title":"J Natl Compr Canc Netw"},{"key":"1288_CR37","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1002\/cam4.1394","volume":"7","author":"J Cha","year":"2018","unstructured":"Cha J, Park HS, Kim D, Kim HJ, Kim MJ, Cho YU, et al. A hierarchical prognostic model for risk stratification in patients with early breast cancer according to 18F-fludeoxyglucose uptake and clinicopathological parameters. Cancer Med. 2018;7:1127\u201334.","journal-title":"Cancer Med"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-018-1288-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-018-1288-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-018-1288-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T19:36:54Z","timestamp":1565293014000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-018-1288-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["1288"],"URL":"https:\/\/doi.org\/10.1007\/s12149-018-1288-2","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,9]]},"assertion":[{"value":"25 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}